N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide
CAS: 52869-18-8
Rif. 3D-CCA86918
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide is a medicinal compound that has shown promising results in the treatment of cancer. It acts as an inhibitor of cyclin-dependent kinases (CDKs), which are proteins that regulate cell cycle progression and are often overexpressed in cancer cells. This analog has been found to induce apoptosis (cell death) in human cancer cells and shows potential as an anticancer agent. Studies have shown that it can inhibit tumor growth in mice and has a favorable safety profile. N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide is excreted primarily through urine and may offer a new avenue for developing targeted cancer therapies.
Proprietà chimiche
Richiesta tecnica su: 3D-CCA86918 N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
